Patients on Cymbalta experienced a statistically longer time to relapse of depression than did patients on placebo. Relapse was defined as an increase of two or more points on the Clinical Global ...
The U.S. Food and Drug Administration announced a Class II recall for more than 7,100 bottles of Duloxetine — a generic antidepressant for Cymbalta — due to a cancerous chemical. A voluntary recall ...
INDIANAPOLIS Eli Lilly and Co.’s anti-depression drug, Cymbalta, has received government approval for long-term use, the company said Friday. The Indianapolis-based drugmaker said that the Food and ...
INDIANAPOLIS, July 6, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it has met the United States Food and Drug Administration (FDA) requirements for pediatric exclusivity ...
It could be another Prozac moment. Eli Lilly and Co. is pitching its next star antidepressant drug, Cymbalta, for approval to treat the poorly understood pain of fibromyalgia. Regulators OK’d a drug ...
But later studies showed, and our previous Consumer Reports Best Buy Drugs report on antidepressants found, that between a third and half of people who take an antidepressant don't benefit very much ...
surged Wednesday after the Indianapolis-based drug company said the federal government had given conditional approval for its antidepressant Cymbalta. The conditions outlined by the Food and Drug ...
The U.S. Food and Drug Administration announced a Class II recall for more than 7,100 bottles of Duloxetine — a generic antidepressant for Cymbalta — due to a cancerous chemical. A voluntary recall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback